Aurora Private Wealth Inc. Makes New Investment in Danaher Corporation (NYSE:DHR)

Aurora Private Wealth Inc. acquired a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 12,521 shares of the conglomerate's stock, valued at approximately $2,567,000.

Other institutional investors have also made changes to their positions in the company. Norges Bank acquired a new position in shares of Danaher during the 4th quarter worth approximately $2,130,740,000. GAMMA Investing LLC boosted its holdings in shares of Danaher by 24,958.2% during the 1st quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock worth $383,524,000 after buying an additional 1,863,381 shares during the period. Raymond James Financial Inc. bought a new position in Danaher in the 4th quarter valued at about $391,172,000. Two Sigma Advisers LP lifted its position in Danaher by 4,248.8% during the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock worth $376,347,000 after acquiring an additional 1,601,800 shares during the last quarter. Finally, Capital World Investors boosted its holdings in shares of Danaher by 32.7% during the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock worth $1,460,215,000 after acquiring an additional 1,566,658 shares during the period. Institutional investors own 79.05% of the company's stock.

Danaher Trading Up 0.4%

DHR traded up $0.88 during midday trading on Thursday, hitting $201.88. 5,562,250 shares of the company were exchanged, compared to its average volume of 3,497,229. The firm has a market capitalization of $144.48 billion, a P/E ratio of 39.20, a P/E/G ratio of 2.82 and a beta of 0.77. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31. The firm's 50 day moving average price is $194.31 and its 200-day moving average price is $209.00.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a return on equity of 10.80% and a net margin of 15.81%. As a group, equities analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.63%. Danaher's dividend payout ratio (DPR) is presently 24.85%.

Insider Transactions at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president now directly owns 15,179 shares in the company, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman now owns 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft cut their target price on Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Argus dropped their target price on shares of Danaher from $260.00 to $240.00 in a research report on Wednesday, April 23rd. Bank of America reduced their price target on shares of Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. Citigroup restated a "buy" rating on shares of Danaher in a research report on Monday, April 7th. Finally, UBS Group decreased their price target on Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $248.61.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.